196 related articles for article (PubMed ID: 19858218)
1. Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells.
Ryu HY; Lee J; Yang S; Park H; Choi S; Jung KC; Lee ST; Seong JK; Han IO; Oh ES
J Biol Chem; 2009 Dec; 284(51):35692-701. PubMed ID: 19858218
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine 51 residue of the syndecan-2 extracellular domain is involved in the interaction with and activation of pro-matrix metalloproteinase-7.
Jang B; Yun JH; Choi S; Park J; Shin DH; Lee ST; Lee W; Oh ES
Sci Rep; 2019 Jul; 9(1):10625. PubMed ID: 31337828
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer.
Jang B; Jung H; Choi S; Lee YH; Lee ST; Oh ES
J Biol Chem; 2017 Sep; 292(39):16321-16332. PubMed ID: 28821612
[TBL] [Abstract][Full Text] [Related]
4. The matrix metalloproteinase-7 regulates the extracellular shedding of syndecan-2 from colon cancer cells.
Choi S; Kim JY; Park JH; Lee ST; Han IO; Oh ES
Biochem Biophys Res Commun; 2012 Jan; 417(4):1260-4. PubMed ID: 22227189
[TBL] [Abstract][Full Text] [Related]
5. Everolimus exerts anticancer effects through inhibiting the interaction of matrix metalloproteinase-7 with syndecan-2 in colon cancer cells.
Lee S; Jang B; Hwang J; Lee Y; Cho S; Yang H; Yun JH; Shin DH; Lee W; Oh ES
Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1067-C1079. PubMed ID: 38314724
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1α promotes extracellular shedding of syndecan-2 via induction of matrix metalloproteinase-7 expression.
Kwon MJ; Hong E; Choi Y; Kang DH; Oh ES
Biochem Biophys Res Commun; 2014 Apr; 446(2):487-92. PubMed ID: 24613844
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-2 enhances E-cadherin shedding and fibroblast-like morphological changes by inducing MMP-7 expression in colon cancer cells.
Jang B; Jung H; Chung H; Moon BI; Oh ES
Biochem Biophys Res Commun; 2016 Aug; 477(1):47-53. PubMed ID: 27270030
[TBL] [Abstract][Full Text] [Related]
8. Shed syndecan-2 enhances tumorigenic activities of colon cancer cells.
Choi S; Choi Y; Jun E; Kim IS; Kim SE; Jung SA; Oh ES
Oncotarget; 2015 Feb; 6(6):3874-86. PubMed ID: 25686828
[TBL] [Abstract][Full Text] [Related]
9. Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1.
Lee H; Kim Y; Choi Y; Choi S; Hong E; Oh ES
Biochem Biophys Res Commun; 2011 May; 409(1):148-53. PubMed ID: 21569759
[TBL] [Abstract][Full Text] [Related]
10. Substituted Syndecan-2-Derived Mimetic Peptides Show Improved Antitumor Activity over the Parent Syndecan-2-Derived Peptide.
Jang B; Kim A; Lee Y; Hwang J; Sung JY; Jang EJ; Kim YN; Yun JH; Han J; Song JJ; Lee W; Oh ES
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682569
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-2 regulates cell migration in colon cancer cells through Tiam1-mediated Rac activation.
Choi Y; Kim H; Chung H; Hwang JS; Shin JA; Han IO; Oh ES
Biochem Biophys Res Commun; 2010 Jan; 391(1):921-5. PubMed ID: 19962968
[TBL] [Abstract][Full Text] [Related]
12. The extracellular domain of syndecan-2 regulates the interaction of HCT116 human colon carcinoma cells with fibronectin.
Kwon MJ; Kim Y; Choi Y; Kim SH; Park S; Han I; Kang DH; Oh ES
Biochem Biophys Res Commun; 2013 Feb; 431(3):415-20. PubMed ID: 23333331
[TBL] [Abstract][Full Text] [Related]
13. Shed syndecan-2 enhances colon cancer progression by increasing cooperative angiogenesis in the tumor microenvironment.
Jang B; Song HK; Hwang J; Lee S; Park E; Oh A; Hwang ES; Sung JY; Kim YN; Park K; Lee YM; Oh ES
Matrix Biol; 2022 Mar; 107():40-58. PubMed ID: 35139425
[TBL] [Abstract][Full Text] [Related]
14. GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression.
Gutschalk CM; Yanamandra AK; Linde N; Meides A; Depner S; Mueller MM
Cancer Med; 2013 Apr; 2(2):117-29. PubMed ID: 23634280
[TBL] [Abstract][Full Text] [Related]
15. New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells.
Han I; Park H; Oh ES
J Mol Histol; 2004 Mar; 35(3):319-26. PubMed ID: 15339051
[TBL] [Abstract][Full Text] [Related]
16. Syndecan-2 overexpression regulates adhesion and migration through cooperation with integrin alpha2.
Choi S; Kim Y; Park H; Han IO; Chung E; Lee SY; Kim YB; Lee JW; Oh ES; Yi JY
Biochem Biophys Res Commun; 2009 Jun; 384(2):231-5. PubMed ID: 19394307
[TBL] [Abstract][Full Text] [Related]
17. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
[TBL] [Abstract][Full Text] [Related]
18. Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.
Peng Z; Chen J; Drachenberg CB; Raufman JP; Xie G
J Biol Chem; 2019 May; 294(21):8529-8542. PubMed ID: 30967475
[TBL] [Abstract][Full Text] [Related]
19. Syndecan-2 regulates the migratory potential of melanoma cells.
Lee JH; Park H; Chung H; Choi S; Kim Y; Yoo H; Kim TY; Hann HJ; Seong I; Kim J; Kang KG; Han IO; Oh ES
J Biol Chem; 2009 Oct; 284(40):27167-75. PubMed ID: 19641225
[TBL] [Abstract][Full Text] [Related]
20. A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression.
Li Z; Mou H; Wang T; Xue J; Deng B; Qian L; Zhou Y; Gong W; Wang JM; Wu G; Zhou CF; Fang J; Le Y
Cancer Lett; 2013 Jan; 328(2):278-84. PubMed ID: 23059759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
